Alterations in immunoglobulin synthesis during adriamycin-induced apoptosis in mouse hybridoma cells

Cell Biology International

Volumn 21, Issue 2, 1997, Pages 69-74

  Meliksetian, M B ^a   Davtyan, T K ^b   Chirkowa, I V ^a   Alexanyan, Yu T ^b   Ignatova, T N ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b Armenian Ministry of Health   (Armenia)

Author keywords

Adriamycin; Apoptosis; Immunoglobulin; Mouse hybridoma

Indexed keywords

ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; DNA FRAGMENT; DOXORUBICIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA DEGRADATION; GENE EXPRESSION REGULATION; HYBRIDOMA; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN PRODUCTION; METAPHASE; MITOSIS INHIBITION; MOUSE; NONHUMAN; NUCLEOSOME; PROTEIN DNA BINDING;

EID: 0031001980     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1996.0116     Document Type: Article

References (30)

1. 12. EMBO J. 14:1995;4994-5005.
2. 2. EMBO J. 11:1995;1392-1401.
3. Baxter GD, Smith PJ, Lavin MF. Molecular changes associated with induction of cell death in a human T-cell leukaemia cell line: putative nucleases identified as histones. Biochem Biophys Res Commun. 162:1989;30-37.
4. Beryozkina EV, Lipskaya LA, Grinchuk TM, Kovaleva ZV, Sorokina EA, Vasyukhin VI, Ignatova TN. The properties of spEBR-5 new multidrug resistant myeloma cell line selected in the presence of ethidium bromide. Citologia. 36:1994;687-692.
5. Constaninou A, Henning-Chubb C, Huberman E. Novobiocin- and phorbol-12-myristate acetate induced differentiation of human leukemia cells associated with reduction of topoisomerase II activity. Cancer Res. 49:1989;1110-1117.
6. Corcoran L, Kawelas M, Nossal G, Ye ZS, Jacks T, Baltimore D. Oct-2 although not required for early B-cell differentiation is critical for later B-cell maturation and postnatal survival. Genes Dev. 7:1993;570-582.
7. 2. J Natl Cancer Inst. 82:1990;749-755.
8. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
9. Fort Ph, Marty L, Picehazyk M, Sabrouty SEl, Jeanteur Ph, Blanchard JM. Various rat adult tissues express only one major mRNA from rat glyceraldehyde-3′-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1442.
10. Gough NM. Rapid and quantitative preparation of cytoplasmic mRNA from small number of cells. Anal Biochem. 173:1988;93-95.
11. Hartwell LH, Weinert TA. Checkpoints: control, that ensure the order of cell cycle events. Science. 246:1989;629-634.
12. Imagawa M, Miyamoto A, Shirakawa M, Hamada H, Muramatsu M. Stringent integrity requirements for both transactivation and DNA binding in a transactivator Oct-3. Nucleic Acids Res. 19:1991;4503-4508.
13. Kaufmann SH, McLaughlin SJ, Kastan MB, Karp JE, Burke PJ. Topoisomerase II levels during granulocytic maturation in vitro and in vivo. Cancer Res. 51:1991;3534-3543.
14. Kelley DE, Perry rP. Transcriptional and post-transcriptional control of immunoglobulin mRNA during B-lymphocyte development. Nucleic Acids Res. 14:1988;5431-5443.
15. Kovaleva ZV, Sinakevich IG, Zavadskaya EE, Beryozkina EV, Pleskach VA, Ignatova TN. Establishment of hybridoma cell line producing of monoclonal antibodies to human transferrin using mouse myeloma cell line SpEBR-5. Citologia. 31:1989;1106-1107.
16. Kohn KW, Pommier Y, Kerrigan D, Markovits S, Covey JM. Topoisomerase II as a target of anticancer drug action in mammalian cells. Natl Cancer Inst Monogr. 4:1987;61-71.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature. 227:1990;680-685.
18. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
19. Martin SG, Bradley JG, Cotter TG. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol. 79:1990;448-453.
20. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
21. Nakajima T, Ohi D, Arai T, Nozaki Kikuchi A, Oda K. Adenovirus E1A-induced apoptosis elicits a steep decrease in the topoisomerase IIα expression during latent phase. Oncogene. 10:1995;651-662.
22. Nelsen B, Sen R. Regulation of immunoglubulin gene transcription. Int Rev Cytol. 133:1992;121-146.
23. Rappa G, Lorico A, Sartorelli AC. Induction of differentiation of WEHI-3BD+ monomyelocytic cells by inhibitors of topoisomerase II. Cancer Res. 50:1990;6723-6730.
24. Tewey KM, Rowe TC, Young LI, Halligan BD, Liu LF. Adriamycin induced DNA damage mediated by mammalian topoisomerase II. Science. 266:1984;466-468.
25. 2. J Natl Cancer Inst. 82:1990;749-755.
26. Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms, inhabitable by bcl-2. Cell. 79:1994;329-339.
27. Strubin M, Newell JW, Mathias P. OBF-1, a novel B-cell specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell. 80:1995;497-506.
28. 2. Oncogene. 10:1995;109-116.
29. Sullivan DM, Lathan MD, Ross WE. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action. Cancer Res. 47:1987;3973-3979.
30. Vinogradov AE, Borkin LJ, Günther R, Rosanov JM. Genome elimination in diploid and triploid RaNa esculenta males: Cytological evidence from DNA flow cytometry. Genome. 33:1990. 619-627.